Skip to content

Pharmacovigilance

Vigilance is our key for patient safety. Patient safety is our primary and main objective!

Statistics & Data Analysis

We choose the right statistical tool and computational model to analyse your data.

Clinical Operations

We streamline clinical operations to provide efficacious solutions for complex projects.

Medical Consulting

Exceptional medical consultations to pharmaceutical and medical device companies!

Medical Writing

Our state of the art medical writing deliverables stand out!

Research & Development

We support drug development pipelines from benchside to "market"side.

Quality Assurance

Top-notch services are our goal. Quality is the essence of success.

Don't Delay!

Don't delay any longer. Schedule your consultation with our team today!

Blogs and Industry News for Pharmacovigilance & Clinical Operations

5-minute weekly newscast – 23/06/2019

By MD Pharma Consulting Group | June 23, 2019

The spotlight is on the researchers at Rice University and the University of Washington. They have 3D-bioprinted a live lung model! This is a major breakthrough in 3D-bioprinting and bioengineering. The major challenge facing 3D-bioprinting of any live organ model is keeping the 3D-bioprinted organs alive. With the 3D-bioprinted live…

Read The Full Article

5-minute weekly newscast – 16/06/2019

By MD Pharma Consulting Group | June 16, 2019

The spotlight is on you. Three weeks ago, everyone was scrutinizing President Donald Trump’s executive order authorizing disclosure of costs across the healthcare industry including drug prices. Literally everyone, politicians, trade groups, lobbyists, and even doctors! But no one asked what do the patients think? According to a survey by…

Read The Full Article

5-minute weekly newscast – 09/06/2019

By MD Pharma Consulting Group | June 9, 2019

The spotlight is on Sanofi Pasteur. The French pharma giant is heading for management shuffle as Sanofi CEO Olivier Brandicourt retires on September 1st, 2019, and Paul Hudson—former president of Novartis’ pharma business—steps in as Sanofi’s new CEO. Hamilton Company and Enable Biosciences have announced their collaboration to provide Hamilton’s Microlab® STAR™…

Read The Full Article

5-minute weekly newscast – 02/06/2019

By MD Pharma Consulting Group | June 2, 2019

The spotlight is on the 2019 ASCO annual meeting. The meeting is due on Friday May 31, 2019 to Tuesday June 4, 2019 at McCormick Place, Chicago, Illinois. The meeting will feature the latest advances in cancer R&D including Merck & Co. immuno-oncology star Keytruda, Novartis’ Kisqali, Pfizer blockbuster Ibrance,…

Read The Full Article

5-minute weekly newscast – 26/05/2019

By MD Pharma Consulting Group | May 26, 2019

The spotlight is on President Donald Trump who will sign an executive order within the next few days authorizing disclosure of costs across the healthcare industry including drug prices. Big Data and advanced data analytics are revolutionizing the industry. Circuit Clinical, an American based patient-oriented integrated research organization, announced partnership…

Read The Full Article

Recent Advances in Treatment of Stage IV Metastatic Breast Cancer

By MD Pharma Consulting Group | May 19, 2019

Breast cancer is the most common cancer type in women worldwide. It is estimated that 70% of patients with breast cancer are estrogen receptor (ER)-positive, making hormonal therapies using ER antagonists and degraders, such as tamoxifen and fulvestrant, common treatments for breast cancer. However, therapies with ER-independent mechanisms are needed…

Read The Full Article

5-minute weekly newscast – 19/05/2019

By MD Pharma Consulting Group | May 19, 2019

The spotlight is on Gilead, a market leader in HIV treatment, who shared the promising news of donating 2.4 million bottles of Truvada to help ending the HIV epidemic in the United States. Astra Zeneca is implementing artificial intelligence and machine learning for the discovery and development of new treatments for chronic…

Read The Full Article

Recent Advances in Treatment of Stage IV Metastatic Non-Small Cell Lung Cancer

By MD Pharma Consulting Group | April 19, 2019

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Approximately 40% of NSCLC patients are diagnosed with stage IV after the tumor has metastasized. As NSCLC is less sensitive to chemotherapy compared to small cell lung cancer (SCLC), research focus has focused on the development of…

Read The Full Article

Choosing the Right Immunoassays for Your Radiobiology Experiments

By MD Pharma Consulting Group | March 21, 2019

Radiation therapy is one of the most common treatments for cancer. In order to improve the treatment efficacy of radiation therapies, radiobiology is the field of basic research that studies the cellular and molecular biological factors influencing the response of cancerous and normal cell lines to ionizing radiation. In a…

Read The Full Article